Zenas Biopharma (ZBIO) News Today $8.72 +0.22 (+2.59%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period ZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIOApril 14 at 4:16 PM | prnewswire.comZenas BioPharma, Inc. Announcement: If You Have Suffered Losses in Zenas BioPharma, Inc. (NASDAQ: ZBIO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsApril 13 at 7:43 AM | globenewswire.comHead-To-Head Comparison: Zenas Biopharma (ZBIO) vs. The CompetitionApril 13 at 2:15 AM | americanbankingnews.comZenas Biopharma (ZBIO) vs. Its Peers Critical ReviewApril 12 at 2:55 AM | americanbankingnews.comHead to Head Contrast: Zenas Biopharma (ZBIO) and Its RivalsApril 12 at 2:55 AM | americanbankingnews.comHead to Head Comparison: Zenas Biopharma (ZBIO) & The CompetitionApril 12 at 2:05 AM | americanbankingnews.comZenas Biopharma (ZBIO) vs. Its Peers Head to Head ReviewApril 11, 2025 | americanbankingnews.comROSEN, A RANKED AND LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – VTRSApril 10, 2025 | globenewswire.comZenas BioPharma, Inc. Investor News: If You Have Suffered Losses in Zenas BioPharma, Inc. (NASDAQ: ZBIO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsApril 10, 2025 | globenewswire.comZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIOApril 9, 2025 | prnewswire.comZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIOApril 9, 2025 | prnewswire.comZenas Biopharma (ZBIO) & The Competition Financial AnalysisApril 9, 2025 | americanbankingnews.comZenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 CatalystApril 7, 2025 | seekingalpha.comZenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific OfficerApril 7, 2025 | globenewswire.comZenas Biopharma (ZBIO) vs. Its Rivals Head-To-Head ComparisonApril 5, 2025 | americanbankingnews.comZenas Biopharma (ZBIO) versus Its Peers Critical SurveyApril 5, 2025 | americanbankingnews.comZenas Biopharma (ZBIO) & The Competition Critical ContrastApril 5, 2025 | americanbankingnews.comROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Quantum Computing Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – QUBTApril 4, 2025 | globenewswire.comROSEN, TRUSTED INVESTOR COUNSEL, Encourages Game of Silks NFT Investors to Secure Counsel Before Important Deadline in Securities Class ActionApril 4, 2025 | globenewswire.comZenas BioPharma, Inc. Announcement: If You Have Suffered Losses in Zenas BioPharma, Inc. (NASDAQ: ZBIO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsApril 1, 2025 | globenewswire.comZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIOMarch 31, 2025 | prnewswire.comZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIOMarch 26, 2025 | prnewswire.comZenas BioPharma, Inc. Announcement: If You Have Suffered Losses in Zenas BioPharma, Inc. (NASDAQ: ZBIO), You Are Encouraged to Contact The Rosen Law Firm About Your RightsMarch 25, 2025 | globenewswire.comQ1 Earnings Forecast for Zenas Biopharma Issued By WedbushZenas Biopharma Inc (NASDAQ:ZBIO - Free Report) - Analysts at Wedbush issued their Q1 2025 earnings per share (EPS) estimates for shares of Zenas Biopharma in a research note issued to investors on Thursday, March 20th. Wedbush analyst M. Fan expects that the company will post earnings per shareMarch 24, 2025 | marketbeat.comZBIO Investor News: Rosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation - ZBIOMarch 21, 2025 | prnewswire.comZenas Biopharma (ZBIO) Expected to Announce Quarterly Earnings on TuesdayZenas Biopharma (NASDAQ:ZBIO) will be releasing earnings before the market opens on Tuesday, March 25.March 21, 2025 | marketbeat.comZenas Biopharma (NASDAQ:ZBIO) Now Covered by Analysts at WedbushWedbush started coverage on Zenas Biopharma in a research report on Thursday. They issued an "outperform" rating and a $35.00 price objective for the company.March 21, 2025 | marketbeat.comRosen Law Firm Encourages Zenas BioPharma, Inc. Investors to Inquire About Securities Class Action Investigation – ZBIOMarch 20, 2025 | businesswire.com Remove Ads Get Zenas Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address ZBIO Media Mentions By Week ZBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZBIO News Sentiment▼0.010.80▲Average Medical News Sentiment ZBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZBIO Articles This Week▼137▲ZBIO Articles Average Week Remove Ads Get Zenas Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ZBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CLDX News INVA News NVAX News OPK News GERN News MYGN News RIGL News VSTM News VNDA News EBS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ZBIO) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zenas Biopharma Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Zenas Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ZBIO Stock Free ZBIO Stock Alerts